154 related articles for article (PubMed ID: 10502421)
21. 17 beta-hydroxysteroid dehydrogenase in common epithelial ovarian tumors.
Sasano H; Suzuki T; Niikura H; Kaga K; Sato S; Yajima A; Rainey WE; Nagura H
Mod Pathol; 1996 Apr; 9(4):386-91. PubMed ID: 8729977
[TBL] [Abstract][Full Text] [Related]
22. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
23. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
24. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
25. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
[TBL] [Abstract][Full Text] [Related]
26. The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep.
Juengel JL; Bibby AH; Reader KL; Lun S; Quirke LD; Haydon LJ; McNatty KP
Reprod Biol Endocrinol; 2004 Nov; 2():78. PubMed ID: 15563738
[TBL] [Abstract][Full Text] [Related]
27. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
28. Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.
Chekerov R; Klaman I; Zafrakas M; Könsgen D; Mustea A; Petschke B; Lichtenegger W; Sehouli J; Dahl E
Neoplasia; 2006 Jan; 8(1):38-45. PubMed ID: 16533424
[TBL] [Abstract][Full Text] [Related]
29. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
[TBL] [Abstract][Full Text] [Related]
30. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
[TBL] [Abstract][Full Text] [Related]
31. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of trypsin in human ovarian carcinomas and low-malignant-potential tumors.
Hirahara F; Miyagi E; Nagashima Y; Miyagi Y; Yasumitsu H; Koshikawa N; Nakatani Y; Nakazawa T; Udagawa K; Kitamura H; Minaguchi H; Miyazaki K
Gynecol Oncol; 1998 Feb; 68(2):162-5. PubMed ID: 9514801
[TBL] [Abstract][Full Text] [Related]
33. Aromatase in human common epithelial ovarian neoplasms.
Kaga K; Sasano H; Harada N; Ozaki M; Sato S; Yajima A
Am J Pathol; 1996 Jul; 149(1):45-51. PubMed ID: 8686761
[TBL] [Abstract][Full Text] [Related]
34. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical assessment of proliferation markers and altered gene expression in archival specimens of ovarian epithelial tumors.
Khalifa MA; Lacher DA; Lage JM; Mannel RS; Walker JL; Angros LH; Min KW
Cancer Detect Prev; 1997; 21(6):532-9. PubMed ID: 9398993
[TBL] [Abstract][Full Text] [Related]
36. Spatiotemporal distribution of SPARC/osteonectin in developing and mature chicken retina.
Kim SY; Ondhia N; Vidgen D; Malaval L; Ringuette M; Kalnins VI
Exp Eye Res; 1997 Nov; 65(5):681-9. PubMed ID: 9367648
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
Naylor MS; Stamp GW; Foulkes WD; Eccles D; Balkwill FR
J Clin Invest; 1993 May; 91(5):2194-206. PubMed ID: 8387543
[TBL] [Abstract][Full Text] [Related]
38. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors.
Iyengar TD; Ng S; Lau CC; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1999 Jan; 18(1):257-62. PubMed ID: 9926941
[TBL] [Abstract][Full Text] [Related]
40. Expression of midkine and pleiotropin in ovarian tumors.
Nakanishi T; Kadomatsu K; Okamoto T; Tomoda Y; Muramatsu T
Obstet Gynecol; 1997 Aug; 90(2):285-90. PubMed ID: 9241309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
